APA (7th ed.) Citation

Ballantyne, C. M., Davidson, M. H., MacDougall, D. E., Bays, H. E., DiCarlo, L. A., Rosenberg, N. L., . . . Newton, R. S. (2013). Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia. Journal of the American College of Cardiology, 62(13), 1154-1162. https://doi.org/10.1016/j.jacc.2013.05.050

Chicago Style (17th ed.) Citation

Ballantyne, Christie M., Michael H. Davidson, Diane E. MacDougall, Harold E. Bays, Lorenzo A. DiCarlo, Noah L. Rosenberg, Janice Margulies, and Roger S. Newton. "Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia." Journal of the American College of Cardiology 62, no. 13 (2013): 1154-1162. https://doi.org/10.1016/j.jacc.2013.05.050.

MLA (9th ed.) Citation

Ballantyne, Christie M., et al. "Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia." Journal of the American College of Cardiology, vol. 62, no. 13, 2013, pp. 1154-1162, https://doi.org/10.1016/j.jacc.2013.05.050.